United States
Joinmochi is the official content presence of Mochi Health, a U.S.-based telehealth platform operating in the fast-growing GLP-1 and metabolic wellness space.
Total Followers +6.7%
52K
Across Instagram
Primary Platform
YouTube
52K followers · 100% of audience
Engagement
0.1%
vs. 1.5% category median
Sponsorship Tier
Micro
Est. $1K–$2.6K / IG post
A U.S. District Judge in San Francisco partially denied Mochi Health's motion to dismiss, clearing Lilly's claims under California's Unfair Competition Law and the federal Lanham Act to move forward.
Founder and CEO Dr. Myra Ahmad represented the company as a featured speaker and roundtable host at the April 17–18 San Francisco summit focused on women's metabolic health and GLP-1 treatments.
The company expanded beyond its cash-pay model with in-network insurance plans covering physician visits, dietitian consults, lab work, genetic testing, and both brand-name and compounded GLP-1 medications.
Lilly alleged Mochi Health violated California's corporate practice of medicine laws and misled consumers by marketing altered compounded versions of Zepbound and Mounjaro. Mochi Health publicly disputed the claims.
| Platform | Followers | 30d Growth | Engagement | Posts / wk | Last upload |
|---|---|---|---|---|---|
| 52,478 | +4K | 0.1% | 7 | 2 days ago |
| Window | Combined | |||
|---|---|---|---|---|
| Last 7 days | +855 +1.6% | +0 +0.0% | +0 +0.0% | +855 |
| Last 30 days | +4K +6.7% | +0 +0.0% | +0 +0.0% | +4K |
| Last 90 days | +8K +14.7% | +0 +0.0% | +0 +0.0% | +8K |
| Last 365 days | +8K +14.7% | +0 +0.0% | +0 +0.0% | +8K |
Daily follower snapshots from CreatorDB's longitudinal index.
Joinmochi is the official content presence of Mochi Health, a U.S.-based telehealth platform operating in the fast-growing GLP-1 and metabolic wellness space. Rather than functioning as a traditional influencer channel, the account serves as a content marketing arm for the company itself, publishing educational posts about GLP-1 weight-loss treatments, peptide therapies, nutrition guidance, and longevity care. The channel's voice blends clinical credibility with accessible, occasionally playful copywriting — mixing FDA regulatory updates with relatable humor and trend-adjacent formats — a deliberate effort to reduce the perceived intimidation of prescription-based healthcare and attract patients who might otherwise find telehealth confusing or inaccessible.
The audience skews heavily female and concentrates in the 25–34 age band, consistent with the demographic most actively researching GLP-1 medications like semaglutide. Domestic U.S. reach dominates, though modest followings in the U.K. and Canada suggest some cross-border interest in the platform's model. Engagement sits below category norms — typical for brand accounts prioritizing reach and awareness over community dialogue — but a notable 30-day follower growth rate signals that GLP-1 content continues to pull new audiences. As the telehealth-plus-weight-management category matures and regulatory scrutiny around compounded peptides intensifies, Mochi Health's ability to produce credible, timely commentary on those developments may become its most durable differentiator in an increasingly crowded direct-to-consumer healthcare market.
Joinmochi reaches an audience concentrated in United States primarily through YouTube, and is best activated via Instagram Reels and Stories. As a fitness creator they map naturally to brands targeting that space. Demonstrated partners include joinmochi. Engagement on YouTube runs around 0.1%, which points to an audience better suited to category-relevant, mid-funnel campaigns than to pure-reach buys. Their YouTube-first format lends itself to integrations that sit inside the creator's usual content rather than running as standalone ads. Because the audience follows fitness content rather than arriving through untargeted reach, sponsorships that match the channel's subject matter tend to convert more efficiently than broad placements. A consistent, on-topic posting focus gives sponsors a predictable, brand-safe environment, lowering placement risk compared with broad, general-interest channels. Campaigns here are best measured on qualified engagement and consideration within the niche rather than on raw impression volume. For United States-focused brands in fitness and related categories, Joinmochi offers a defined, creative-fit audience rather than broad, low-intent impressions.
Benchmark estimates for a creator at Joinmochi's tier (Micro, 52K combined followers, United States). Pulled from CreatorDB's category benchmarks.
The CreatorDB Agency runs end-to-end influencer campaigns globally — shortlisting, outreach, contracting, and performance reporting. Talk to our team about building a campaign around creators in this niche.
Mochi Health is a US-based telehealth platform built around the idea that healthcare should work for the patient, starting with GLP-1 weight loss treatments. Through their platform, patients can access prescriptions for GLP-1 medications along with support for longevity, hair care, and skin care. Their social handle, @joinmochi, is where they educate and engage their patient community online.
Yes, GLP-1 medications for weight loss are central to what Mochi Health offers through their telehealth platform. They connect patients with providers who can write prescriptions as part of a personalized weight management plan. Mochi Health also actively covers the regulatory landscape around GLP-1 access on their social channels to keep patients informed.
Mochi Health prices GLP-1 medications based on the patient's actual dose rather than a flat rate, which they position as a fairer alternative to one-size-fits-all pricing. This model is designed to make GLP-1 access more cost-transparent for people at different stages of their treatment. Specific pricing is available through the Mochi Health platform directly.
Yes, Mochi Health covers significantly more than GLP-1 weight loss. Their platform also provides access to longevity treatments, hair care, and skin care, positioning them as a broader telehealth wellness destination. This range is spelled out in their own Instagram bio and reflected consistently across their content.
Mochi Health posted a breakdown of an FDA review of peptide access, framing it as cutting through the noise on what is "actually up for debate" for patients. Peptides are part of Mochi's treatment offerings, so the regulatory outcome directly affects what their patients can access. They've made it part of their brand voice to translate complex policy questions into plain language for their community.
Yes, Mochi Health has explicitly stated that a GLP-1 journey "shouldn't stop at the prescription" and that nutrition is a critical part of the process. Their approach integrates nutritional guidance alongside medication management rather than treating the prescription as the end point. This reflects a whole-patient philosophy that distinguishes them from platforms that only handle the Rx side.
Mochi Health references peptides as part of their treatment lineup alongside GLP-1 medications, longevity care, and skin treatments, and peptides appear consistently in their content hashtags. They've also covered the FDA's review of peptide access, which signals that availability may shift with regulation. For current peptide options, patients would need to consult directly through the Mochi Health platform.
Mochi Health is a US-based telehealth company, and the substantial majority of their social audience is located in the United States, which aligns with their platform operating within the US healthcare and regulatory system. Their services — particularly GLP-1 prescriptions — are designed around US medical licensing and FDA rules. International visitors may follow their content but access to treatments is US-focused.
Mochi Health's Instagram skews heavily female and is most concentrated in the 25–44 age range, which maps closely to the demographic most actively researching GLP-1 medications and telehealth wellness options. Their content blends educational explainers on GLP-1s and peptides with relatable, trend-forward formats to reach people at the research stage of their health journey. It's designed for both current patients and people considering starting treatment.
"Joinmochi" is the social handle for Mochi Health — the "join" is a direct invitation for prospective patients to join the platform. Mochi (🍡) is a Japanese rice cake adopted as an approachable, non-clinical brand name to make healthcare feel less intimidating. Mochi Health has leaned into this playful identity on social media, even joking about logo changes and platform trends to keep their tone relatable.
Stats (followers, engagement, audience demographics, growth) are pulled live from the CreatorDB API covering YouTube, Instagram and TikTok. Bio and FAQ content is AI-assisted; news items are sourced from cited public press at generation time. Read the full methodology →
If you'd like to update, correct, or remove this profile, get in touch and we'll handle it within 5 business days. We don't publish private data — every stat shown comes from your public platform profiles.
@joinmochi · YouTube
+0 new followers
Preparing fresh data…
This usually takes 15–25 seconds.